GENI shareholder plans sale of 202,876 common shares
A holder of GENI common stock filed a notice to sell shares under Rule 144.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
A holder of GENI common stock filed a notice to sell shares under Rule 144. The filing covers 202,876 common shares, to be sold through Fidelity Brokerage Services LLC, with an aggregate market value of $2,253,729.20. These shares relate to a recent restricted stock vesting on 01/02/2026, received from the issuer as compensation on that date.
The notice identifies the intended trading market as the NYSE, with an approximate sale date of 01/05/2026. It also discloses that the same seller previously sold 400,673 common shares on 11/10/2025, generating $4,167,039.27 in gross proceeds. The filing reports that 214,097,454 common shares were outstanding for the issuer at the time referenced.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What representation does the seller make about GENI in this notice?
By signing the notice, the seller represents that they do not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed.
AI-generated analysis. How Rhea-AI works. Not financial advice.